560 related articles for article (PubMed ID: 19949037)
21. Standard preanalytical coding for biospecimens: defining the sample PREanalytical code.
Betsou F; Lehmann S; Ashton G; Barnes M; Benson EE; Coppola D; DeSouza Y; Eliason J; Glazer B; Guadagni F; Harding K; Horsfall DJ; Kleeberger C; Nanni U; Prasad A; Shea K; Skubitz A; Somiari S; Gunter E;
Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1004-11. PubMed ID: 20332280
[TBL] [Abstract][Full Text] [Related]
22. Utilization of Mobile Application for Better Implementation of Good Clinical Practice in a Biorepository Sample Collection Process: Functions of
Tian L; Zhang K; Wang X; Jiang K; Gao W; Liang N; Wang X; Miao Y; Lu Z
Biopreserv Biobank; 2020 Apr; 18(2):46-52. PubMed ID: 31910345
[TBL] [Abstract][Full Text] [Related]
23. [Current best practices and biobanking recomedations.].
Doludin YV; Borisova AL; Pokrovskaya MS; Stefanyuk OV; Sivakova OV; Botsoeva SA; Meshkov AN; Metelskaya VA; Drapkina OM
Klin Lab Diagn; 2019; 64(12):769-776. PubMed ID: 32040903
[TBL] [Abstract][Full Text] [Related]
24. Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality.
Roberts JN; Karvonen C; Graham K; Weinfeld M; Joy AA; Koebel M; Morris D; Robson PJ; Johnston RN; Brockton NT
Adv Exp Med Biol; 2015; 864():95-114. PubMed ID: 26420616
[TBL] [Abstract][Full Text] [Related]
25. Biobanking and Beyond: The Importance of Scientific Collections.
Vaught J
Biopreserv Biobank; 2019; 17(1):1. PubMed ID: 30759029
[No Abstract] [Full Text] [Related]
26. Sustainability in Biobanking: Model of Biobank Graz.
Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
[TBL] [Abstract][Full Text] [Related]
27. International approaches to advancing biospecimen science.
Moore HM; Compton CC; Alper J; Vaught JB
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):729-32. PubMed ID: 21430299
[TBL] [Abstract][Full Text] [Related]
28. Biobanking in genomic medicine.
Zhou JH; Sahin AA; Myers JN
Arch Pathol Lab Med; 2015 Jun; 139(6):812-8. PubMed ID: 26030251
[TBL] [Abstract][Full Text] [Related]
29. Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers.
Huang J; Khademi M; Lindhe Ö; Jönsson G; Piehl F; Olsson T; Kockum I
Mol Cell Proteomics; 2021; 20():100157. PubMed ID: 34597789
[TBL] [Abstract][Full Text] [Related]
30. A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.
Park SA; Kang JH; Kang ES; Ki CS; Roh JH; Youn YC; Kim SY; Kim SY
J Clin Neurol; 2015 Apr; 11(2):132-41. PubMed ID: 25851891
[TBL] [Abstract][Full Text] [Related]
31. Biobanking trends, challenges, and opportunities.
Mackenzie F
Pathobiology; 2014; 81(5-6):245-251. PubMed ID: 25792213
[TBL] [Abstract][Full Text] [Related]
32. Procurement, Storage, and Use of Blood in Biobanks.
Perry JN; Jasim A; Hojat A; Yong WH
Methods Mol Biol; 2019; 1897():89-97. PubMed ID: 30539437
[TBL] [Abstract][Full Text] [Related]
33. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks.
Bernini P; Bertini I; Luchinat C; Nincheri P; Staderini S; Turano P
J Biomol NMR; 2011 Apr; 49(3-4):231-43. PubMed ID: 21380509
[TBL] [Abstract][Full Text] [Related]
34. Toward a common language for biobanking.
Fransson MN; Rial-Sebbag E; Brochhausen M; Litton JE
Eur J Hum Genet; 2015 Jan; 23(1):22-8. PubMed ID: 24713663
[TBL] [Abstract][Full Text] [Related]
35. ["Standard" protocol for evaluating the impact of preanalytical variables on peptidic and proteic analytes and standard coding of preanalytical procedures].
Betsou F; Beaudeux JL; Berthelaix A; Borg J; Dupuy A; Lizard G; Peoc'h K; Quillard M; Lehmann S
Ann Biol Clin (Paris); 2009; 67(6):641-9. PubMed ID: 19939767
[TBL] [Abstract][Full Text] [Related]
36. Comparison and Analysis of Two Internationally Recognized Biobanking Standards.
Tarling T; O'Donoghue S; Barnes R; Carvalho K; Gali B; Castelhano M; Mes-Masson AM; Watson PH
Biopreserv Biobank; 2020 Apr; 18(2):82-89. PubMed ID: 31985265
[TBL] [Abstract][Full Text] [Related]
37. Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy.
Giannella E; Notarangelo V; Motta C; Sancesario G
Neuroscientist; 2023 Apr; 29(2):190-201. PubMed ID: 34353130
[TBL] [Abstract][Full Text] [Related]
38. China Biobanking.
Zhang Y; Li Q; Wang X; Zhou X
Adv Exp Med Biol; 2015; 864():125-40. PubMed ID: 26420618
[TBL] [Abstract][Full Text] [Related]
39. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
40. Protein Quality Assessment on Saliva Samples for Biobanking Purposes.
Rosa N; Marques J; Esteves E; Fernandes M; Mendes VM; Afonso Â; Dias S; Pereira JP; Manadas B; Correia MJ; Barros M
Biopreserv Biobank; 2016 Aug; 14(4):289-97. PubMed ID: 26937781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
